Obstetrics & Gynecology Doctors in Springville, NY Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Jane D Kraft, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 21 E Main St, Springville, NY 14141 Phone: 716-592-8931    Fax: 716-592-2152

Dr. Dalip Kumar Khurana, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15 Commerce Dr, Springville, NY 14141 Phone: 716-592-4166    Fax: 716-592-4177

Nicholas Lloyd Cromwell, MD Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 27 Franklin St, Springville, NY 14141 Phone: 716-592-7400

Dr. Virginia Kathryn Bond, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 230 S Cascade Dr, Springville, NY 14141 Phone: 716-675-5222

News Archive

Rite Aid announces acquisition of Houston-based RediClinic

Rite Aid Corporation announced today it has acquired Houston-based RediClinic, one of the nation's leading operators of retail clinics. RediClinic currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Through the acquisition, RediClinic will operate as a wholly owned subsidiary of Rite Aid. Details of the transaction were not disclosed.

Liberia's House of Representatives passes HIV/AIDS confidentiality act

Liberia's House of Representatives on Tuesday passed the Anti-HIV/AIDS Act, which would make it unlawful to disclose a person's HIV/AIDS status without that individual's prior consent, Liberia's News reports.

Extensive folic acid fortification of foods prevents neural tube defects in neonates

Neural tube defects in neonates are common in Germany compared with the rest of Europe. Extensive folic acid fortification of foods in Germany might prevent these in 85-100% of cases, Wolfgang Herrmann and Rima Obeid argue in this issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2011; 108[15]; 249-54).

Medac Pharma announces FDA acceptance of New Drug Application for MPI-2505

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced the FDA acceptance of its New Drug Application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection device, for which the proposed indications are rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis.

Bacterial binding in the stomach

Scientists have determined that decay-accelerating factor (DAF), a protein found in epithelial cells in the stomach, acts as a receptor for the bacteria Helicobacter pylori. Blocking this interaction could lead to new drugs that reduce the risk of peptic ulcer disease or gastric cancer.

Read more Medical News

› Verified 5 days ago